Lars Matkin, MD
Orthopaedic Surgery · Anchorage, AKNPI 1891292884
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $6,150 of the $9,108 with a category attached, or 67.5%. 16 manufacturers reported payments, led by Stryker at 45.5% of the total.
Across 80 payments — averaging $113.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Zimmer Biomet$2K
- Johnson & Johnson$2K
- Alaska Medical Technologies, LLC$163
- Acumed LLC$143
- Medacta USA, Inc.$100
- plus $458 from 10 others
What the payments were for
- Travel & lodging$6,15068%
- Food & beverage$2,56728%
- Education$3914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 38 | $4,141 |
| Zimmer Biomet | 13 | $2,435 |
| Johnson & Johnson | 5 | $1,668 |
| Alaska Medical Technologies, LLC | 2 | $163 |
| Acumed LLC | 5 | $143 |
| Medacta USA, Inc. | 1 | $100 |
| Summit Surgical Corp. | 2 | $82 |
| Smith+Nephew | 2 | $79 |
| Medtronic | 1 | $76 |
| Bioventus LLC | 4 | $66 |
| Arthrex | 1 | $48 |
| Mimedx Group, Inc. | 1 | $30 |
| Medinc Of Texas | 1 | $30 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Abbott | 1 | $15 |
| Orthofix Medical, Inc. | 2 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Avenir$1,895
- INSPACE$1,155
- MAKO$1,101
- ATTUNE$519
- PANGEA$472
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$452
- Persona$278
- GMK SPHERE$100
How this compares
$9,108 in reported general payments places this provider in the 75th percentile of 63 orthopaedic surgery providers in Alaska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 37 | $646 |
| Meloxicam | 66 | $155 |
| Cyclobenzaprine Hcl | 11 | $49 |
| Tramadol Hcl | 21 | $49 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Anchorage
- Bryan HaughomAnchorage$179K
- Benjamin PackardAnchorage$40K
- Kenneth ThomasAnchorage$35K
- Jason GrayAnchorage$17K
- Ian BrimhallAnchorage$17K
- Thomas PaynterAnchorage$14K
- Kevin PaisleyAnchorage$10K
- Daniel CepelaAnchorage$9K
- Adam EllisonAnchorage$8K
- Bradley SparksAnchorage$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.